In contrast, prostate adenocarcinoma (PRAD), kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), and colon adenocarcinoma (COAD) exhibited significantly reduced ATP6V0D2 expression compared to normal tissues. The gene discussed is ATP6V0D2; the disease is lung adenocarcinoma.